158 related articles for article (PubMed ID: 38137482)
1. Left Atrial Low-Voltage Areas Predict the Risk of Atrial Fibrillation Recurrence after Radiofrequency Ablation.
Mitran RE; Popa-Fotea NM; Iorgulescu C; Nastasa A; Pupaza A; Gondos V; Petre IG; Paja SC; Vatasescu RG
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137482
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Left Atrial Fibrosis and Success of Catheter Ablation by Speckle Tracking Echocardiography in Patients Imaged in Persistent Atrial Fibrillation.
Marchandise S; Garnir Q; Scavée C; Varnavas V; le Polain de Waroux JB; Wauters A; Beauloye C; Roelants V; Gerber BL
Front Cardiovasc Med; 2022; 9():856796. PubMed ID: 35694674
[TBL] [Abstract][Full Text] [Related]
3. The Extent of Left Atrial Low-Voltage Areas Included in Pulmonary Vein Isolation Is Associated With Freedom from Recurrent Atrial Arrhythmia.
Huang D; Li JB; Zghaib T; Gucuk Ipek E; Balouch M; Spragg DD; Ashikaga H; Tandri H; Sinha SK; Marine JE; Berger RD; Calkins H; Nazarian S
Can J Cardiol; 2018 Jan; 34(1):73-79. PubMed ID: 29275886
[TBL] [Abstract][Full Text] [Related]
4. Voltage mapping and pulmonary vein isolation in master athletes with atrial fibrillation.
Liu B; Pagan E; Beccarino N; Chang D; Dulmovits E; Beldner S
Pacing Clin Electrophysiol; 2022 Nov; 45(11):1338-1342. PubMed ID: 36196004
[TBL] [Abstract][Full Text] [Related]
5. Low-voltage areas detected by high-density electroanatomical mapping predict recurrence after ablation for paroxysmal atrial fibrillation.
Vlachos K; Efremidis M; Letsas KP; Bazoukis G; Martin R; Kalafateli M; Lioni L; Georgopoulos S; Saplaouras A; Efremidis T; Liu T; Valkanas K; Karamichalakis N; Asvestas D; Sideris A
J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1393-1402. PubMed ID: 28884923
[TBL] [Abstract][Full Text] [Related]
6. Atrial substrate characterization in patients with atrial fibrillation and hypertrophic cardiomyopathy: Evidence for an extensive fibrotic disease.
Efremidis M; Bazoukis G; Vlachos K; Prappa E; Anastasakis A; Megarisiotou A; Dragasis S; Asvestas D; Mililis P; Saplaouras A; Efremidis T; Batsouli A; Zimpounoumi N; Valkanas K; Sideris A; Letsas KP
J Electrocardiol; 2021; 69():87-92. PubMed ID: 34619440
[TBL] [Abstract][Full Text] [Related]
7. Left atrial total emptying fraction measured by cardiovascular magnetic resonance imaging predicts low-voltage areas detected during electroanatomical mapping.
Löbe S; Stellmach P; Darma A; Hilbert S; Paetsch I; Jahnke C; Bollmann A; Hindricks G; Kircher S
Europace; 2023 Nov; 25(11):. PubMed ID: 37960936
[TBL] [Abstract][Full Text] [Related]
8. Association between left atrial low-voltage area, serum apoptosis, and fibrosis biomarkers and incidence of silent cerebral events after catheter ablation of atrial fibrillation.
Müller P; Maier J; Dietrich JW; Barth S; Griese DP; Schiedat F; Szöllösi A; Halbfass P; Nentwich K; Roos M; Krug J; Schade A; Schmitt R; Mügge A; Deneke T
J Interv Card Electrophysiol; 2015 Oct; 44(1):55-62. PubMed ID: 26048130
[TBL] [Abstract][Full Text] [Related]
9. Associations of the fibrosis-4 index with left atrial low-voltage areas and arrhythmia recurrence after catheter ablation: cardio-hepatic interaction in patients with atrial fibrillation.
Yamada S; Kaneshiro T; Nodera M; Amami K; Nehashi T; Oikawa M; Yamaki T; Nakazato K; Ishida T; Takeishi Y
J Arrhythm; 2024 Jun; 40(3):585-593. PubMed ID: 38939777
[TBL] [Abstract][Full Text] [Related]
10. Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.
Masuda M; Fujita M; Iida O; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Okuno S; Ohashi T; Tsuji A; Mano T
Int J Cardiol; 2018 Apr; 257():97-101. PubMed ID: 29506746
[TBL] [Abstract][Full Text] [Related]
11. Validating left atrial fractionation and low-voltage substrate during atrial fibrillation and sinus rhythm-A high-density mapping study in persistent atrial fibrillation.
Huang T; Chen J; Müller-Edenborn B; Mayer L; Eichenlaub M; Moreno Weidmann Z; Allgeier J; Bohnen M; Lehrmann H; Trenk D; Schoechlin S; Westermann D; Arentz T; Jadidi A
Front Cardiovasc Med; 2022; 9():1000027. PubMed ID: 36330001
[TBL] [Abstract][Full Text] [Related]
12. Circulating MicroRNA-21 Correlates With Left Atrial Low-Voltage Areas and Is Associated With Procedure Outcome in Patients Undergoing Atrial Fibrillation Ablation.
Zhou Q; Maleck C; von Ungern-Sternberg SNI; Neupane B; Heinzmann D; Marquardt J; Duckheim M; Scheckenbach C; Stimpfle F; Gawaz M; Schreieck J; Seizer P; Gramlich M
Circ Arrhythm Electrophysiol; 2018 Jun; 11(6):e006242. PubMed ID: 29848477
[TBL] [Abstract][Full Text] [Related]
13. Impact of unipolar voltage criteria for left atrial posterior wall on atrial fibrillation recurrence after pulmonary vein isolation.
Watanabe T; Watanabe H; Hachiya H; Sato M; Mitama T; Okuyama T; Yokota A; Kamioka M; Komori T; Kabutoya T; Imai Y; Kario K
J Cardiovasc Electrophysiol; 2023 Apr; 34(4):849-859. PubMed ID: 36738145
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of left atrial remodeling by 2D-speckle-tracking echocardiography versus by high-density voltage mapping in patients with atrial fibrillation.
Laish-Farkash A; Perelshtein Brezinov O; Valdman A; Tam D; Rahkovich M; Kogan Y; Marincheva G
J Cardiovasc Electrophysiol; 2021 Feb; 32(2):305-315. PubMed ID: 33331056
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Pulmonary Vein Anatomy on the Outcomes of Catheter Ablation for Atrial Fibrillation.
Istratoaie S; Roșu R; Cismaru G; Vesa ȘC; Puiu M; Zdrenghea D; Pop D; Buzoianu AD
Medicina (Kaunas); 2019 Nov; 55(11):. PubMed ID: 31690031
[No Abstract] [Full Text] [Related]
16. Impact of Voltage Mapping to Guide Whether to Perform Ablation of the Posterior Wall in Patients With Persistent Atrial Fibrillation.
Cutler MJ; Johnson J; Abozguia K; Rowan S; Lewis W; Costantini O; Natale A; Ziv O
J Cardiovasc Electrophysiol; 2016 Jan; 27(1):13-21. PubMed ID: 26515166
[TBL] [Abstract][Full Text] [Related]
17. Elevated Circulating Fibrocytes Is a Marker of Left Atrial Fibrosis and Recurrence of Persistent Atrial Fibrillation.
Liu Y; Niu XH; Yin X; Liu YJ; Han C; Yang J; Huang X; Yu X; Gao L; Yang YZ; Xia YL; Li HH
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535140
[TBL] [Abstract][Full Text] [Related]
18. Impact of metabolic syndrome on left atrial electroanatomical remodeling and outcomes after radiofrequency ablation of nonvalvular atrial fibrillation.
Dinov B; Kosiuk J; Kircher S; Bollmann A; Acou WJ; Arya A; Hindricks G; Rolf S
Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):483-9. PubMed ID: 24833645
[TBL] [Abstract][Full Text] [Related]
19. High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation.
Decoin R; Butruille L; Defrancq T; Robert J; Destrait N; Coisne A; Aghezzaf S; Woitrain E; Gouda Z; Schino S; Klein C; Maboudou P; Brigadeau F; Klug D; Vincentelli A; Dombrowicz D; Staels B; Montaigne D; Ninni S
Front Endocrinol (Lausanne); 2022; 13():957245. PubMed ID: 36120456
[TBL] [Abstract][Full Text] [Related]
20. Contact electroanatomic mapping derived voltage criteria for characterizing left atrial scar in patients undergoing ablation for atrial fibrillation.
Kapa S; Desjardins B; Callans DJ; Marchlinski FE; Dixit S
J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1044-52. PubMed ID: 24832482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
